home / stock / pbd / pbd news


PBD News and Press, Invesco Global Clean Energy From 07/01/20

Stock Information

Company Name: Invesco Global Clean Energy
Stock Symbol: PBD
Market: NYSE

Menu

PBD PBD Quote PBD Short PBD News PBD Articles PBD Message Board
Get PBD Alerts

News, Short Squeeze, Breakout and More Instantly...

PBD - Some clean energy ETFs shine in brutal first half for fossil fuels

The energy sector is the worst performing stock market sector in the first half, with plunging oil prices and consumer demand alongside heavy debt loads among the driving factors. More news on: Energy Select Sector SPDR ETF, Invesco Exchange-Traded Fund Trust - Invesco Dynamic Oil & Ga...

PBD - The Rise Of Carbon Pricing And Impact On Earnings

Carbon pricing going global Carbon pricing is growing, whether with national schemes or companies internal pricing, as ESG issues go mainstream. It is set to imminently expand to some of the world's largest carbon emitters, China and the Transport (Shipping, Airlines) sector. The COVID rec...

PBD - Going Green: Oil & Gas Dips Its Toes Into Renewables

The dramatic growth of US oil and natural gas production over the last decade has transformed the US energy landscape by reducing our dependence on coal for electricity generation and exponentially increasing energy exports. Another transformation is underway as power providers and policymaker...

PBD - Protalix BioTherapeutics Appoints Yael Hayon, Ph.D. as its New Vice President, Research and Development

CARMIEL, Israel, June 8, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX) today announced the appointment of Yael Hayon , Ph.D. as the Company's new Vice President, Research and Development, effective July 5, 2020. On June 2, 2020 , Yos...

PBD - Coronavirus Asks Questions Of Renewables As Well As Oil

Renewable energy projects and investments used to be very elastic to oil prices movement. However that is no longer the case. In fact, even when oil prices tumble, demand for renewable energy only keeps growing. For instance, before the coronavirus pandemic, energy from solar power became very...

PBD - Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease

CARMIEL, Israel , May 28, 2020 /PRNewswire/ --  Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ®...

PBD - Biggest drop in global energy investment ever

The coronavirus crisis been "staggering in both its scale and swiftness," warned the IEA in its annual World Energy Investment report, stating global energy investment will tumble by 20% - or by $400B - compared to last year. More news on: Energy Select Sector SPDR ETF, SPDR S&P Oil ...

PBD - Protalix BioTherapeutics to Hold First Quarter 2020 Financial Results and Business Update Conference Call on June 1, 2020

CARMIEL, Israel , May 22, 2020 Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell-based pro...

PBD - Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease

CARMIEL, Israel , May 11, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® pla...

PBD - Protalix BioTherapeutics Announces Closing of $43.7 Million Private Placement

CARMIEL, Israel , March 18, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plan...

Previous 10 Next 10